Broadcast Date: April 14th, 2015
Time: 11:00 am ET, 8:00 am PT
This online webinar will address how target-enrichment tools for next-generation sequencing can be used to identify clinically relevant and tumor-specific mutations in clinical research samples.
Margarete Odenthal, research scientist at the University Hospital Cologne, will discuss how her team used a disease-focused approach to analyze the mutation status of different tumors and its application in a clinical cancer research setting.
Vikram Devgan, director of biological research content at QIAGEN, will talk about the critical success factors necessary to move from sample acquisition to NGS data analysis and interpretation with BRCA1/2 genes.
Who Should Attend
- Clinical research scientists
- Cancer scientists
- Clinical investigators
- NGS users, core lab managers & directors
- NGS service providers
- Cancer biologists
You Will Learn
- How to go from clinical samples to valuable molecular insights using NGS.
- How to target a wide range of cancer-related genes or genomic regions.
- The critical factors for successful implementation of targeted DNA sequencing.
Produced with support from:
Margarete Odenthal, Ph.D.
University Hospital Cologne
Vikram Devgan, Ph.D.
Head of Biological Research Content,